FARALLON CAPITAL PARTNERS LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 09:00 am Purchase |
2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,956,488 9.990% |
191,379 (+3.32%) |
Filing |
| 2024-02-02 09:19 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,765,109 9.990% |
710,007 (+14.05%) |
Filing |
| 2023-02-09 4:54 pm Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,055,102 9.990% |
5,055,102 (New Position) |
Filing |